Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
NEUROG2 and ZGRF1 antisense RNA 1 (NEUROG2-AS1) is a long non-coding RNA (lncRNA) gene found in humans[3][4]. As an antisense transcript to the NEUROG2 and ZGRF1 genes, it does not code for a protein but may act as a regulatory RNA. Long non-coding RNAs like NEUROG2-AS1 are known to have diverse functions in gene regulation, frequently impacting transcription processes, mRNA stability, and chromatin states[1]. Although the detailed biological role of NEUROG2-AS1 remains uncharacterized in the peer-reviewed literature, antisense lncRNAs at similar loci often participate in fine-tuning the expression of nearby protein-coding genes, such as NEUROG2, which is essential for neuronal differentiation[1][3][4]. There are no known direct disease associations, interacting drugs, or established uses of NEUROG2-AS1 as a biomarker or therapeutic target[3][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on NEUROG2 and ZGRF1 antisense RNA 1 (NEUROG2-AS1).